JP Morgan analyst Christopher Neyor downgrades Kala Pharmaceuticals (NASDAQ:KALA) from Neutral to Underweight and announces $1.5 price target.
Analyst Ratings for Hewlett Packard
Within the last quarter, Hewlett Packard (NYSE:HPE) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…